炎症性肠病中进展期结直肠肿瘤的动态预测
该研究汇总加拿大、荷兰、英国和美国6项队列研究数据,纳入3731例需结直肠癌监测的炎症性肠病患者,基于里程碑法和Cox比例风险模型开发并验证进展期结直肠肿瘤的动态预测模型。模型含8个预测因子,5年和10年预测窗口的交叉验证中位一致性统计量分别为0.74和0.75,校准良好,但内部-外部交叉验证显示泛化性结果不一。
要点
- 模型含8个预测因子,5年与10年预测窗口交叉验证中位一致性统计量分别为0.74和0.75。
- 校准图显示校准良好,内部-外部交叉验证显示中等区分度和合理至良好的校准。
- 作者认为未来研究应聚焦正式外部验证并将预测风险与监测间隔关联后方可临床应用。
核心结论
- 新预测模型显示良好的区分度和校准度,但泛化性结果不一。
- 未来研究应聚焦正式外部验证,并在临床应用前将预测的进展期结直肠肿瘤风险与监测间隔相关联。
研究设计与样本
- 汇总来自加拿大、荷兰、英国和美国的6项现有队列研究数据。
- 纳入有结直肠癌监测指征且至少接受1次随访操作的炎症性肠病患者,排除既往进展期结直肠肿瘤、既往结肠切除术或监测指征不明确者。
- 预测变量基于文献选择,采用基于Cox比例风险模型的里程碑法开发动态预测模型。
- 模型性能通过Harrell一致性统计量(区分度)和校准曲线评估,并通过内部-外部交叉验证评估跨监测队列的泛化性。
主要发现
- 监测队列共纳入3731例患者,入组和随访时间为1973年至2021年,中位随访5.7年(26336患者年随访),146例诊断为进展期结直肠肿瘤。
- 模型含8个预测因子,5年和10年预测窗口的交叉验证中位一致性统计量分别为0.74和0.75。
- 校准图显示校准良好。
- 内部-外部交叉验证结果显示中等区分度和合理至良好的校准。
局限性
- 泛化性结果不一。
- 未来研究应聚焦正式外部验证并在临床应用前将预测风险与监测间隔相关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Colonoscopic surveillance is recommended in patients with colonic inflammatory bowel disease (IBD) given their increased risk of colorectal cancer (CRC). We aimed to develop and validate a dynamic prediction model for the occurrence of advanced colorectal neoplasia (aCRN, including high-grade dysplasia and CRC) in IBD. METHODS: We pooled data from 6 existing cohort studies from Canada, The Netherlands, the United Kingdom, and the United States. Patients with IBD and an indication for CRC surveillance were included if they underwent at least 1 follow-up procedure. Exclusion criteria included prior aCRN, prior colectomy, or an unclear indication for surveillance. Predictor variables were selected based on the literature. A dynamic prediction model was developed using a landmarking approach based on Cox proportional hazard modeling. Model performance was assessed with Harrell's concordance-statistic (discrimination) and by calibration curves. Generalizability across surveillance cohorts was evaluated by internal-external cross-validation. RESULTS: The surveillance cohorts comprised 3731 patients, enrolled and followed-up in the time period from 1973 to 2021, with a median follow-up period of 5.7 years (26,336 patient-years of follow-up evaluation); 146 individuals were diagnosed with aCRN. The model contained 8 predictors, with a cross-validation median concordance statistic of 0.74 and 0.75 for a 5- and 10-year prediction window, respectively. Calibration plots showed good calibration. Internal-external cross-validation results showed medium discrimination and reasonable to good calibration. CONCLUSIONS: The new prediction model showed good discrimination and calibration, however, generalizability results varied. Future research should focus on formal external validation and relate predicted aCRN risks to surveillance intervals before clinical application.
引用
- Wijnands AM, Penning de Vries BBL, Lutgens MWMD, et al. Dynamic Prediction of Advanced Colorectal Neoplasia in Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2024. PMID: 38431223. doi:10.1016/j.cgh.2024.02.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。